methazolamide
Selected indexed studies
- Methazolamide. (, 2006) [PMID:30000740]
- Methazolamide in high-altitude illnesses. (Eur J Pharm Sci, 2020) [PMID:32251722]
- Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry. (Cell Metab, 2022) [PMID:35150639]
_Worker-drafted node — pending editorial review._
Connections
methazolamide is a side effect of
Sources
- Methazolamide. (2006) pubmed
- Methazolamide in high-altitude illnesses. (2020) pubmed
- Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry. (2022) pubmed
- Methazolamide Can Treat Atherosclerosis by Increasing Immunosuppressive Cells and Decreasing Expressions of Genes Related to Proinflammation, Calcification, and Tissue Remodeling. (2024) pubmed
- The Impact of Acetazolamide and Methazolamide on Exercise Performance in Normoxia and Hypoxia. (2023) pubmed
- Association between HLA-B*5901 and methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis. (2019) pubmed
- Structure and mechanism of carbonic anhydrase. (1997) pubmed
- Optimization of methazolamide-loaded solid lipid nanoparticles for ophthalmic delivery using Box-Behnken design. (2014) pubmed
- Diuretics. (2012) pubmed
- Procoagulant platelet activation promotes venous thrombosis. (2024) pubmed